Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 378532

Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis


Tomić, Monika; Galešić, Krešimir; Markota, Ivica
Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis // Renal failure, 30 (2008), 9; 836-842 doi:10.1080/08860220802356218 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 378532 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis

Autori
Tomić, Monika ; Galešić, Krešimir ; Markota, Ivica

Izvornik
Renal failure (0886-022X) 30 (2008), 9; 836-842

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
ACE inhibitors; enothelin-1; hemodialysis; hypertension; nitric oxide

Sažetak
The pathogenesis of renal hypertension has not yet been fully clarified. As the potential role of endothelin-1 (ET-1) and nitric oxide (NO) has been postulated, their concentrations were determined in plasma and urine of diabetic patients. The study included 30 diabetic patients (both IDDM and NIDDM) with initial or advanced diabetic nephropathy (decreased endogenous creatinine clearance, proteinuria) and 20 healthy control subjects. The correlation with blood pressure and other renal function parameters was monitored and compared with the control group. Also, the effect of ACE inhibitors (ACEI) on ET-1 and NO patterns was monitored in correlation with arterial hypertension. In diabetic patients that did not receive ACEI therapy, the increase in plasma ET-1 was associated with both systolic and diastolic blood pressure elevation, whereas in those administered ACEI the increase in plasma ET-1 was associated with a systolic blood pressure decline. In addition, the increase in plasma NO was accompanied by a statistically significant decline of both systolic and diastolic blood pressure in diabetic patients receiving ACEI.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
198-0000000-0179 - Prognostički čimbenici progresije bubrežne insuficijencije (Galešić, Krešimir, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"

Profili:

Avatar Url Monika Tomić (autor)

Avatar Url Krešimir Galešić (autor)

Poveznice na cjeloviti tekst rada:

doi informahealthcare.com

Citiraj ovu publikaciju:

Tomić, Monika; Galešić, Krešimir; Markota, Ivica
Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis // Renal failure, 30 (2008), 9; 836-842 doi:10.1080/08860220802356218 (međunarodna recenzija, članak, znanstveni)
Tomić, M., Galešić, K. & Markota, I. (2008) Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis. Renal failure, 30 (9), 836-842 doi:10.1080/08860220802356218.
@article{article, author = {Tomi\'{c}, Monika and Gale\v{s}i\'{c}, Kre\v{s}imir and Markota, Ivica}, year = {2008}, pages = {836-842}, DOI = {10.1080/08860220802356218}, keywords = {ACE inhibitors, enothelin-1, hemodialysis, hypertension, nitric oxide}, journal = {Renal failure}, doi = {10.1080/08860220802356218}, volume = {30}, number = {9}, issn = {0886-022X}, title = {Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis}, keyword = {ACE inhibitors, enothelin-1, hemodialysis, hypertension, nitric oxide} }
@article{article, author = {Tomi\'{c}, Monika and Gale\v{s}i\'{c}, Kre\v{s}imir and Markota, Ivica}, year = {2008}, pages = {836-842}, DOI = {10.1080/08860220802356218}, keywords = {ACE inhibitors, enothelin-1, hemodialysis, hypertension, nitric oxide}, journal = {Renal failure}, doi = {10.1080/08860220802356218}, volume = {30}, number = {9}, issn = {0886-022X}, title = {Endothelin-1 and Nitric Oxide in Patients on Chronic Hemodialysis}, keyword = {ACE inhibitors, enothelin-1, hemodialysis, hypertension, nitric oxide} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font